Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
CYLD expressed with phosphorylated TDP-43, phosphorylated p62, and Lys63-linked ubiquitin in the nuclear and perinuclear regions of muscle fibres of wild-type TDP-43 TG mice and the degenerative myofibres of sIBM patients with rimmed vacuoles and endomysial cellular infiltration.
|
31406156 |
2019 |
Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
Our observation suggested that TDP-43 aggregates might not be sufficient to trigger the pathogenesis of sIBM although myofiber sarcoplasmic aggregation of TDP-43 led to myofiber degeneration via ER stress and possibly calcium dysregulation, independently of inflammatory process.
|
30130494 |
2018 |
Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to present clinical and muscle histopathological findings, including immunostaining for LC3B, p62, <i>α</i>-synuclein, and TDP-43, in 18 patients with sIBM.
|
29780824 |
2018 |
Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
Using cultured cells and mouse skeletal muscle, we show that TDP-43 acetylation-mimics promote TDP-43 phosphorylation and ubiquitination, perturb mitochondria, and initiate degenerative inflammatory responses that resemble sporadic inclusion body myositis pathology.
|
28724966 |
2017 |
Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
Pathological deposits of TDP-43 were found in muscles in all sIBM as well as in control cases.
|
26785370 |
2015 |
Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
Here, we exploit high quality RNA from frozen sIBM muscle biopsies for transcriptomic studies on TDP43-proteinopathy patient tissue.
|
24462217 |
2014 |
Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
TDP-43, OPTN and, to a lesser extent, FUS/TLS were more frequently accumulated in the cytoplasm in patients with sIBM and OPMD than in patients with PM, DM, neurogenic muscular atrophy, or healthy control subjects.
|
22860700 |
2013 |
Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
Myonuclear structural abnormalities and the presence of nucleic acid-binding proteins, including the TAR DNA binding protein TDP-43, in sporadic inclusion body myositis (sIBM) sarcoplasm are important recent observations.
|
19680126 |
2009 |
Inclusion Body Myopathy, Sporadic
|
0.090 |
Biomarker
|
disease |
BEFREE |
This study adds sIBM and hereditary inclusion body myopathies to the growing list of TDP-43 positive inclusion diseases.
|
18796596 |
2008 |